| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
SAB Biotherapeutics Inc (NASDAQ: SABS)
SABS Technical Analysis
5
| As on 9th Jun 2023 SABS STOCK Price closed @ 0.91 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.52 & Strong Sell for SHORT-TERM with Stoploss of 5.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SABSSTOCK Price
| Open | 0.92 | Change | Price | % |
| High | 0.95 | 1 Day | -0.01 | -1.09 |
| Low | 0.90 | 1 Week | 0.02 | 2.25 |
| Close | 0.91 | 1 Month | 0.01 | 1.11 |
| Volume | 33153 | 1 Year | -7.63 | -89.34 |
| 52 Week High 9.03 | 52 Week Low 0.38 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SABS Daily Charts |
SABS Intraday Charts |
Whats New @ Bazaartrend |
SABS Free Analysis |
|
|
SABS Important Levels Intraday
| RESISTANCE | 1.01 |
| RESISTANCE | 0.98 |
| RESISTANCE | 0.96 |
| RESISTANCE | 0.94 |
| SUPPORT | 0.88 |
| SUPPORT | 0.86 |
| SUPPORT | 0.84 |
| SUPPORT | 0.81 |
SABS Forecast May 2024
| 4th UP Forecast | 7.15 |
| 3rd UP Forecast | 5.15 |
| 2nd UP Forecast | 3.91 |
| 1st UP Forecast | 2.68 |
| 1st DOWN Forecast | -0.86 |
| 2nd DOWN Forecast | -2.09 |
| 3rd DOWN Forecast | -3.33 |
| 4th DOWN Forecast | -5.33 |
SABS Weekly Forecast
| 4th UP Forecast | 3.51 |
| 3rd UP Forecast | 2.68 |
| 2nd UP Forecast | 2.16 |
| 1st UP Forecast | 1.65 |
| 1st DOWN Forecast | 0.17 |
| 2nd DOWN Forecast | -0.34 |
| 3rd DOWN Forecast | -0.86 |
| 4th DOWN Forecast | -1.69 |
SABS Forecast2024
| 4th UP Forecast | 17.83 |
| 3rd UP Forecast | 12.4 |
| 2nd UP Forecast | 9.05 |
| 1st UP Forecast | 5.7 |
| 1st DOWN Forecast | -3.88 |
| 2nd DOWN Forecast | -7.23 |
| 3rd DOWN Forecast | -10.58 |
| 4th DOWN Forecast | -16.01 |
SAB Biotherapeutics Inc ( NASDAQ USA Symbol : SABS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SABS Business Profile
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service